Terms: = Thyroid cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p
34 results:
1. Obesity correlates with the immunosuppressive ILC2s-MDSCs axis in advanced breast cancer.
Liu W; Li B; Liu D; Zhao B; Sun G; Ding J
Immun Inflamm Dis; 2024 Mar; 12(3):e1196. PubMed ID: 38501542
[TBL] [Abstract] [Full Text] [Related]
2. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
3. APC mutation correlated with poor response of immunotherapy in colon cancer.
Li B; Zhang G; Xu X
BMC Gastroenterol; 2023 Mar; 23(1):95. PubMed ID: 36977982
[TBL] [Abstract] [Full Text] [Related]
4. Implications of PD-1, Tim-3, and TIGIT Expression for cancer Immunity and Pancreatic cancer Prognosis.
Nakayama C; Tanoue K; Idichi T; Shimomura H; Kita Y; Hozaka Y; Shinden Y; Matsushita D; Nakajo A; Arigami T; Mataki Y; Kurahara H; Ohtsuka T
Anticancer Res; 2022 Jul; 42(7):3373-3380. PubMed ID: 35790289
[TBL] [Abstract] [Full Text] [Related]
5. Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression.
Qi M; Xia Y; Wu Y; Zhang Z; Wang X; Lu L; Dai C; Song Y; Xu K; Ji W; Zhan L
Nat Commun; 2022 Feb; 13(1):897. PubMed ID: 35173168
[TBL] [Abstract] [Full Text] [Related]
6. False-Positive 123I-Uptake Mimics Metastatic Lung Disease in a Patient With Interstitial Lung Disease Secondary to Scleroderma.
Posocco D; Kamat B; Dadparvar S
Clin Nucl Med; 2022 Jan; 47(1):79-80. PubMed ID: 34284476
[TBL] [Abstract] [Full Text] [Related]
7. Resuscitative Endovascular Balloon Occlusion of the Aorta for Blood Control in Lumbar Spine Tumor Resection Surgery: A Technical Note.
Zhao YJ; Du XC; Deng XQ; Zhang H; Zhang HR; Qiao RQ; Zhang JY; Hu YC
Orthop Surg; 2021 Jul; 13(5):1540-1545. PubMed ID: 34086401
[TBL] [Abstract] [Full Text] [Related]
8. PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells.
Liotti F; Kumar N; Prevete N; Marotta M; Sorriento D; Ieranò C; Ronchi A; Marino FZ; Moretti S; Colella R; Puxeddu E; Paladino S; Kano Y; Ohh M; Scala S; Melillo RM
J Exp Clin Cancer Res; 2021 Jan; 40(1):22. PubMed ID: 33413561
[TBL] [Abstract] [Full Text] [Related]
9. Procathepsin V Is Secreted in a TSH Regulated Manner from Human thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe.
Al-Hashimi A; Venugopalan V; Rehders M; Sereesongsaeng N; Hein Z; Springer S; Weber E; Führer D; Bogyo MS; Scott CJ; Burden RE; Brix K
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266306
[TBL] [Abstract] [Full Text] [Related]
10.
Vos L; Dietrich J; Strieth S; Bootz F; Dietrich D; Franzen A
Immunotherapy; 2020 Aug; 12(12):903-920. PubMed ID: 32684057
[No Abstract] [Full Text] [Related]
11. Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.
Presotto EM; Rastrelli G; Desideri I; Scotti V; Gunnella S; Pimpinelli N; Vaccher E; Bearz A; Di Costanzo F; Bruggia M; Mini E; Maggi M; Peri A
J Endocrinol Invest; 2020 Mar; 43(3):337-345. PubMed ID: 31542865
[TBL] [Abstract] [Full Text] [Related]
12. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
Yoo SK; Song YS; Lee EK; Hwang J; Kim HH; Jung G; Kim YA; Kim SJ; Cho SW; Won JK; Chung EJ; Shin JY; Lee KE; Kim JI; Park YJ; Seo JS
Nat Commun; 2019 Jun; 10(1):2764. PubMed ID: 31235699
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
Álvarez-Sierra D; Marín-Sánchez A; Ruiz-Blázquez P; de Jesús Gil C; Iglesias-Felip C; González Ó; Casteras A; Costa RF; Nuciforo P; Colobran R; Pujol-Borrell R
J Autoimmun; 2019 Sep; 103():102285. PubMed ID: 31182340
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
Yan J; Wang R; Wu Z
J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
[TBL] [Abstract] [Full Text] [Related]
15. PROGRAMMED CELL DEATH-LIGAND 1 OVEREXPRESSION IN thyroid cancer.
Zhang GQ; Wei WJ; Song HJ; Sun ZK; Shen CT; Zhang XY; Chen XY; Qiu ZL; Luo QY
Endocr Pract; 2019 Mar; 25(3):279-286. PubMed ID: 30913016
[TBL] [Abstract] [Full Text] [Related]
16. Nivolumab-induced hypothyoidism with consequent hypothyroid related myopathy.
Johnson ED; Kerrigan K; Butler K; Patel SB
J Oncol Pharm Pract; 2020 Jan; 26(1):224-227. PubMed ID: 30880569
[TBL] [Abstract] [Full Text] [Related]
17. [Initially undetected de novo psoriasis triggered by nivolumab for metastatic base of the tongue carcinoma].
Troyanova-Slavkova S; Eickenscheidt L; Dumann K; Kowalzick L
Hautarzt; 2018 Aug; 69(8):674-680. PubMed ID: 29330579
[TBL] [Abstract] [Full Text] [Related]
18. Endocrine side effects of cancer immunotherapy.
Cukier P; Santini FC; Scaranti M; Hoff AO
Endocr Relat Cancer; 2017 Dec; 24(12):T331-T347. PubMed ID: 29025857
[TBL] [Abstract] [Full Text] [Related]
19. Incidental Primary Intradural Carcinoid Tumor in a Patient with Lumbar Radiculopathy.
Koustais S; O'Halloran PJ; Hassan A; Brett F; Young S
World Neurosurg; 2017 Sep; 105():1042.e11-1042.e14. PubMed ID: 28705700
[TBL] [Abstract] [Full Text] [Related]
20. Recommendations for cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased cancer Risk.
Villani A; Greer MC; Kalish JM; Nakagawara A; Nathanson KL; Pajtler KW; Pfister SM; Walsh MF; Wasserman JD; Zelley K; Kratz CP
Clin Cancer Res; 2017 Jun; 23(12):e83-e90. PubMed ID: 28620009
[TBL] [Abstract] [Full Text] [Related]
[Next]
